Loading…
The Type 1 Diabetes-Resistance Locus Idd22 Controls Trafficking of Autoreactive CTLs into the Pancreatic Islets of NOD Mice
Type 1 diabetes (T1D) has a strong genetic component. The ( ) locus was identified in crosses of T1D-susceptible NOD mice with the strongly T1D-resistant ALR strain. The NODcALR-( )/Mx (NOD- ) recombinant congenic mouse strain was generated in which NOD mice carry the full confidence interval. NOD-...
Saved in:
Published in: | The Journal of immunology (1950) 2017-12, Vol.199 (12), p.3991-4000 |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Type 1 diabetes (T1D) has a strong genetic component. The
(
)
locus was identified in crosses of T1D-susceptible NOD mice with the strongly T1D-resistant ALR strain. The NODcALR-(
)/Mx (NOD-
) recombinant congenic mouse strain was generated in which NOD mice carry the full
confidence interval. NOD-
mice exhibit almost complete protection from spontaneous T1D and a significant reduction in insulitis. Our goal was to unravel the mode of
-based protection using in vivo and in vitro models. We determined that
did not impact immune cell diabetogenicity or β cell resistance to cytotoxicity in vitro. However, NOD-
mice were highly protected against adoptive transfer of T1D. Transferred CTLs trafficked to the pancreatic lymph node and proliferated to the same extent in NOD and NOD-
mice, yet the accumulation of pathogenic CTLs in the islets was significantly reduced in NOD-
mice, correlating with disease resistance. Pancreatic endothelial cells from NOD-
animals expressed lower levels of adhesion molecules, even in response to inflammatory stimuli. Lower adhesion molecule expression resulted in weaker adherence of T cells to NOD-
endothelium compared with NOD-derived endothelium. Taken together, these results provide evidence that
regulates the ability of β cell-autoreactive T cells to traffic into the pancreatic islets and may represent a new target for pharmaceutical intervention to potentially prevent T1D. |
---|---|
ISSN: | 0022-1767 1550-6606 |
DOI: | 10.4049/jimmunol.1602037 |